Business Context and Reporting Period
Purple Innovation, Inc. (PRPL), an emerging growth company incorporated in Delaware, filed this Form 8-K on March 9, 2020. The filing serves to announce the Company's financial results for the fiscal year ended December 31, 2019, via a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) and are not explicitly detailed in the body of this 8-K report. The Company notes that the press release includes non-GAAP financial measures with reconciliations to GAAP measures.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the text provided. It references the attached press release for the full announcement of results for the year ended December 31, 2019.
Guidance, Outlook, and Risks
Management commentary regarding the evaluation of period-to-period results is referenced in the attached press release. The filing states that the information furnished pursuant to Item 2.02 and the exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference in any filing under the Securities Act or Exchange Act except as expressly set forth by specific reference. No specific risks, contingencies, or unusual items are detailed in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 9, 2020) for specific revenue, net income, and cash flow figures for the year ended December 31, 2019.
- Examine the reconciliation of non-GAAP financial measures to GAAP measures included in the press release.
- Verify the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbols: Class A Common Stock (PRPL) on NASDAQ and Warrants (PRPLW) on OTC PINK.